
Avantel Q4 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
Yes
Capex
Yes
3 of 5 growth signals are positive.
Full analysisRevenue guidance
Category 2- →The company expects a 25% Compound Annual Growth Rate (CAGR) in sales over the next 3 years.
- →Projected revenues: ₹300 crores in the first year, ₹375-400 crores in the second, and around ₹500 crores in the third, totaling approximately ₹1,100 crores.
- →Current order book stands at about ₹1,000 crores, supporting this growth.
- →Growth to continue similarly in the 4th and 5th years, maintaining the 25% CAGR.
- →Increased R&D investments and new product lines (iDEX, SDR products, SATCOM ground stations) to drive future revenue.
- →Expansion into civilian sectors, such as fishing boats under PM’s project, contributing to diversified revenue streams.
- →The long-term plan includes reaching ₹1,000+ crores in sales, potentially scaling to ₹1,500-2,000 crores with existing infrastructure.
- →Growth depends on government policies, satellite launches, and market dynamics in defense and space sectors.
Margin guidance
Category 3- →Confident 25% CAGR growth expected for the next 3 years, with visibility unprecedented in company history.
- →Revenue target of ₹1,000 crores anticipated within this period, potentially scaling to ₹1,500-2,000 crores without new infrastructure.
- →EPS and return on capital employed expected to improve year-on-year over the next 3 years, assured due to existing orders and margins.
- →Profit margins vary by product mix and tender type; no specific guidance given on EBITDA margins due to competitive bidding variables.
- →2026-27 seen as an investment year with increased R&D and capital expenditure, impacting short-term profits but benefiting long-term growth.
- →Strategic plans include expansion in defense, civilian, satellite, and potentially energy sectors to sustain order continuity and scale.
- →Company maintains transparency, though sensitive financial details or order-wise margins are withheld for competitive reasons.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →The company has completed its rights issue process and successfully utilized the funds as per objectives, monitored by CARE.
- →No immediate plan for fresh equity increase; assurances given that return on capital employed and EPS will improve without raising equity in the next 3 years.
- →The Board is exploring the possibility of finding a strategic investor for the healthcare/Medicare segment, which may involve selling a majority stake; this is under serious consideration but not finalized.
- →Any strategic investment will be subject to professional valuation, Board and shareholder approval, ensuring transparency.
- →Working capital limits were increased with bank support (Canara Bank, SBI), with sanctioned borrowing limits around ₹250 crores (out of approved ₹350 crores), and still have unused borrowing scope.
- →Financial management is conservative with low debt-equity (~0.1) and healthy interest coverage (approx. 11 times).
Order book
Yes- →Avantel Limited has a visible order book for the next 3 years, a first in the company's history.
- →The company expects a CAGR of 25% and aims to reach ₹1,000 crores revenue at the earliest in the next 3 years.
- →Orders include satellite ground stations for NSIL (Govt. of India) involving 9 units to be built over 18 months.
- →Rate contract orders worth approximately ₹460 crores, with ₹160 crores attributed to AMC over 5 years.
- →Orders include defense-related SDRs with expected market size of ₹3,000 crores/year, targeting at least 20% share.
- →Completion of current orders expected during FY 2026-27, a crucial R&D investment year.
- →Growth dependent on government policies, satellite launches, and frequency allocations.
- →Working capital and bank credit limits are adequate to support order executions.
Capex plans
Yes- →The company invested significantly in capital equipment and infrastructure to enhance capacity and address diverse market segments.
- →A new 100,000 sq. ft. R&D facility was inaugurated, predominantly for R&D activities with some production, supporting about 180 engineers.
- →Depreciation on new capital assets increased by ₹7 crores in the past year, reflecting these investments.
- →Future strategic investment considerations include exploring a strategic investor for the healthcare/Medicare division, potentially involving a majority stake sale subject to valuation and Board/shareholders approval.
- →The company is exploring diversification into the energy sector for steady order flow and larger contract opportunities.
- →Capacity expansion allows for potential revenues of ₹1,000 to ₹2,000 crores without major new infrastructure.
- →Overall, current and future capex is focused on R&D, capacity enhancement, and strategic diversification with Board and shareholder involvement.
How does Avantel rank vs peers in Aerospace & Defense?
Pro featureSee full Aerospace & Defense sector rankings
How does Avantel rank in Aerospace & Defense?
Compare Avantel against every Aerospace & Defense company (Q4 FY26) on revenue, margins and earnings-call signals.